Cargando…
The past, present, and future of disease-modifying therapies for Alzheimer’s disease
The development of disease-modifying therapies for Alzheimer’s disease (AD) is an urgent issue. Progress in the understanding of AD pathophysiology based on the amyloid hypothesis has led to the development of numerous candidate disease-modifying therapies over the past 15 years. The therapeutic tar...
Autores principales: | SUZUKI, Kazushi, IWATA, Atsushi, IWATSUBO, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Academy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790756/ https://www.ncbi.nlm.nih.gov/pubmed/29225305 http://dx.doi.org/10.2183/pjab.93.048 |
Ejemplares similares
-
Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018) -
Molecular Pathogenesis and Disease-modifying Therapies of Alzheimer’s Disease and Related Disorders
por: Iwatsubo, Takeshi
Publicado: (2022) -
Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019) -
Attempt to Predict A/T/N-Based Alzheimer’s Disease Cerebrospinal Fluid Biomarkers Using a Peripheral Blood DNA Methylation Clock
por: Sato, Kenichiro, et al.
Publicado: (2020) -
Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study
por: Sato, Kenichiro, et al.
Publicado: (2021)